Igg and igm based immunopathological reaction reaction of hypersensitivity type ii
1 / 58

IgG and IgM based immunopathological reaction (reaction of hypersensitivity type II). - PowerPoint PPT Presentation

  • Uploaded on

IgG and IgM based immunopathological reaction (reaction of hypersensitivity type II). = antibody-dependent. antibodies produced by the immune response bind to antigens on the patient's own cell surfaces. intrinsic ("self" antigen, innately part of the patient's cells).

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about ' IgG and IgM based immunopathological reaction (reaction of hypersensitivity type II).' - charo

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Igg and igm based immunopathological reaction reaction of hypersensitivity type ii
IgG and IgM based immunopathological reaction (reaction of hypersensitivity type II).

  • = antibody-dependent

  • antibodies produced by the immune response bind to antigens on the patient's own cell surfaces

  • intrinsic ("self" antigen, innately part of the patient's cells)

  • extrinsic (absorbed onto the cells during exposure to some foreign antigen, possibly as part of infection with a pathogen)

  • These cells are recognized by macrophages or dendritic cells which act as antigen presenting cells, this causes a B cell response where antibodies are produced against the foreign antigen.

Igg and igm based immunopathological reaction reaction of hypersensitivity type ii1
IgG and IgM based immunopathological reaction (reaction of hypersensitivity type II)

  • Autoimmune hemolytic anemia

  • Goodpasture's syndrome

  • Autoimmune pernicious anemia

  • Immune thrombocytopenia

  • Transfusion reactions

  • Myasthenia gravis

  • Rheumatic fever

  • Acute transplant rejection

Immun e complex based immunopathological reaction reaction of hypersensitivity type iii
Immun hypersensitivity type II)e complex based immunopathological reaction (reaction of hypersensitivity type III)

  • occurs when antigens and antibodies are present in roughly equal amounts, causing extensive cross-linking

  • large immune complexes that cannot be cleared are deposited in vessel walls and induce an inflammatory response

  • the reaction can take hours, days, or even weeks to develop

Immun e complex based immunopathological reaction reaction of hypersensitivity type iii1
Immun hypersensitivity type II)e complex based immunopathological reaction (reaction of hypersensitivity type III)

Some clinical examples:

  • Rheumatoid arthritis

  • Immune complex glomerulonephritis

  • Serum sickness

  • Subacute bacterial endocarditis

  • Systemic lupus erythematosus

  • Farmer's lung (Arthus-type reaction)

  • Polyarteritis nodosa

Primary immunodeficiency

PRIMARY IMMUNODEFICIENCY hypersensitivity type II)

clinical manifestactions


IMMUNODEFICIENCY hypersensitivity type II)

  • Primary immunodeficiencies

    - congenital, genetically defined disorders

    - onset of symptoms - predominantly at an early


  • Secondary immunodeficiencies

    - caused by chronic infections, irradiation,

    injuries, immunosupression therapy, surgery,


    - disorders appear at any age

IMMUNIDEFICIENCY hypersensitivity type II)

  • Humoral deficiency disorders

    = the B cell deficiency disorders – the qualitative or quantitative defects of the B cells, present 70% of IDs

  • T cell deficiency disorders and the combined B-cell and T-cell deficiency disorders (20%) – group of the qualitative or quantitative defects of the T and B cells

  • Phagocytic celldisorders– group of the qualitative or quantitative defects of the fagocytic cells (10%)

  • Complement disorders – caused by the deficiency of the complement components or functions (<1%)

Major clinical features
MAJOR CLINICAL FEATURES hypersensitivity type II)

  • Humoral deficiency disorders - manifest as the recurrent bacterial sinopulmonary and gastrointestinal infections

    - caused by streptococcus, staphylococcus, haemophilus, begin when infants are 5-9 months of age

  • T cell disorders - manifest as the recurrent bacterial, fungal and viral respiratory and gastrointestinal infection

  • Complement disorders – are associated with increased incidence of the infections and autoimmune diseases and with edema in the case of hereditary angioedema

  • Phagocytic celldisorders – characterized by recurrent infections caused by various organisms incluging abscesses, purulent skin infections, granulomatousinflammations

Humoral deficiency disorders

  • Bruton’s X-linkedhypogamaglobulinemia

  • CVID - Common Variable ImmunoDeficiency

  • Selective immunoglobulin A deficiency <0,07 g/l

Bruton s x linked hypogamaglobulinemia
Bruton’s hypersensitivity type II)X-linkedhypogamaglobulinemia

  • the genetic defect on the X chromosome leads to the defective function of a tyrosine kinase in the B cells

  • This defect result in a block of the pre-B cells maturation into the B cells with surface IgM

  • the immunologic findings: < 2% circulating B cells

    - low serum levels of all classes of immunoglobulins

    - number and function of T cells are intact

    - pre-B cells are in the bone marrow

  • features : begining from 5-9 months of age

    - manifests as recurrent bacterial sinopulmonary and gastrointestinal infection caused by streptococcus, staphylococcus, haemophilus, meningococcus, salmonella, campylobacter, giardia

  • Treatment consists of life-long intravenous pooled human gammaglobulin replacement and antibiotics.

Common variable immunodeficiency
Common Variable hypersensitivity type II)ImmunoDeficiency

  • the B cell functional disorder characterized by the normal number

    of the B cells, low levels of IgG and IgA, a poor response to all

    vaccines and decrease of the T cells (CD4+) number and function

  • the symptom’s onset between 2ndand 3rddecade

  • the clinical features:

    - recurrent respiratory tract infections (pneumonia), cutaneous and

    gastrointestinal infection

    - disease is accompanied by occurrence of the granulomas,

    lymphadenopathy, splenomegaly

  • Treatment consist of the intramuscular or intravenous

    gammaglobulin replacement.

Selective deficiency of iga
Selective deficiency of IgA hypersensitivity type II)

  • level of IgA up to 0,05 g/l, age > 4 years

  • the most frequent primary ID

    - stem cell defect

    - repeated infections of respiratory tract

    - susceptibility to autoimmune disorders, malignant disorders, allergy

    - contra-indication of administration of drug with IgA

T cell deficiency disorders
T cell deficiency disorders hypersensitivity type II)

  • DiGeorge syndrome

    - the genetic defect on the chromosome 22 leads to disorder of

    development of 3rdand 4thbranchial pouch with congenital

    hypoplasia of both the thymus and parathyroid glands

    - patients suffer from disorder of pre-thymocytes maturation due to

    absence/hypoplasia of thymus

    - syndrome CATCH 22: cardiac defects, abnormal facies, thymic

    hypo/aplasia, cleft palate, hypocalcemia, deletion 22q11.2

    - the symptom’s onset soon after the birth – hypocalcemic spasms

    andmanifestations of congenital heart disease

    - treatment: symptomatic, transplantation of a thymus

Primary fagocytic cell defects

Chronic granulomatous disease

- X- linked recesive disorder - leads to defect in neutrophilic cytochrome b with suppresion of intracellular killing of ingested microorganisms

- normal number of leucocytes

- infection of catalase-positive bacterias

- symptoms appear in the first year of age: pyogenic cutaneous

infections, abscesses, granulomas in many organs, pyogenic


- treatment: long-term ATB administration, interferon gamma,


Complement deficiency
COMPLEMENT DEFICIENCY hypersensitivity type II)

  • C2, C3, C4 complement components deficiencies

    - lead to an impaired opsonization, susceptibility to infections,

    autoimune diseases

  • C6, C7, C8, C9complement components deficiencies

    - lead to the autoimmune diseases – SLE, RA, sclerodermia and to

    the neisserial infection

  • MBLdeficiencies

    - lead to the respiratory infections and susceptibility to the

    autoimune and allergy diseases

  • Treatment: vaccination, ATB

Hereditary angioedema

HEREDITARY hypersensitivity type II) ANGIOEDEMA


clinical manifestations


Hereditary angioedema1
HEREDITARY ANGIOEDEMA hypersensitivity type II)

  • the congenital AD complement disorder cased by the defect on the chromosome 11

  • leads to absence orfunctional deficiency of C1-inhibitor

  • C4 a C2 complement components show a low level

    during atack

  • Type I - occurs in 85%

    - an absence of C1-inhibitor

  • Type II - occurs in 15%

    - a functional deficiency of C1-inhibitor

  • Secondary - SLE, lymfoma

Hereditary angioedema2
HEREDITARY ANGIOEDEMA hypersensitivity type II)

  • C1 esterase inhibitor deficiency leads to uncontrolled C1 activity and resultant production of a kinin that increases capillary permeability

  • Clinical feature: transient recurrent localized edema

  • the triggering factors: injuries or surgical/stomatological operations

  • more offen occures in pregnancy

  • laryngeal edema could be life-threatening, immediate treatment is necessary !

TREATMENT hypersensitivity type II)

  • Preventive – consist of an administration of androgens, a-fibrinolytics

    - before operation is necessary C1-INH concentrate or a

    fresh frozen plasma administration

    - stomatology procedures are performed in hospital

  • Immediate - C1-INH concentrate or fresh frozen plasma administration

  • tracheotomy in severe larynx edema

  • treatment with ACE inhibitorsis contraindicated

Acquired immunodeficiencies



mechanisms involved


Acquired immunodeficiencies1

  • Acute and chronic viral infections – EBV, CMV, herpetic virus, influenza, HIV

  • Metabolic disorders– diabetes, renal failure, disorder of liver function

  • Autoimmune diseases– autoantibodies against immunocompetent cells (neutrophils, lymphocytes)

  • Allergic diseases

  • ChronicGIT diseases, nephrotic syndrome

  • Malignant diseases(leukemia, lymphoma, myeloma)

  • Hypersplenism/asplenia, splenectomy – deficiency in generation of antibodies against encapsulated microorganisms(Pneumococcus, Neisseria)

  • Burn, postoperative status, injuries

  • Severe nutritional disorders, chronic stress

  • Drug induced immunodeficiencies(chemotherapy), immunosupression

  • Chronic exposureto harmfulchemical substances, ionizing radiation

AIDS hypersensitivity type II)

  • Acquired ImmunoDeficiency Syndrom

    - caused by a retrovirus called human immunodeficiency virus

    - current incidence 40 mil.people, predominantly in central Africa, CZ – about 1000 infected people

  • viral transmission occurs through:

    - sexual intercourse

    - contact with blood

    - transplacentally, during the birth process or

    through a breast milk

Virus hiv 1
VIRUS HIV-1 hypersensitivity type II)

  • virion is consisted of a capside with marrow protein - p24 and RNA

  • RNA is copied into double-stranded DNA using reverse transcriptase

  • virus integrates to the human cell genome and arise a provirus

  • an activation of provirus leads to the replication of viral nuclear acid and genesis of a virion that goes through the cell membrane and caused the lysis of cell

Primary infection
PRIMARY INFECTION hypersensitivity type II)

  • Infection - begins by HIV-1 with a tropism for macrofages:

    - the membrane molecules of dendritic cells bind

    glycoproteins on HIV-1 surface and transport viruses to the lymphatic nodes (LN), where activated T cells are infected viruses are replicated in the lymphatic nodes and transfer to the blood

  • features: malaise, fever, pain of muscles and joints, sweating, loss of appetite, vomiting, diarrhoea, rash, lymphadenopathy

  • Immunological findings: elevated C-reactive protein, lymphopenia, decrease of CD4+ cells

  • specific antibodies against HIV-1 don‘t generate

  • identification of viruses is performed by PCR or by the evidence of viral protein p24 presence

Asymptomatic periode
ASYMPTOMATIC PERIODE hypersensitivity type II)

  • asymptomatic period – HIVs-1 with a tropism for macrophages are changed into viruses with a tropism for T cells and demage T cells (CD4+)

  • viruses replicate in cell secondary lymphatic organs

    - the period can last a several years

  • lasting depends on:

    - virus doses and virulence

    - an individual condition of immune system an infected


    - an acceleration occures by repeated infection of

    different HIVs

AIDS hypersensitivity type II)

  • AIDS- Related Complex (ARC) presents with lymphadenopathy and comes before fully developed AIDS

  • Clinical features of AIDS :

    - candidiasis of mouth and esophagous

    mucose, colpitis

    - oral leucoplakia, opportunistic infections

    - Kaposi sarcoma, non-Hodgkin‘s lymfoma

VACCINE hypersensitivity type II)

  • development of a vaccine is unsuccessful

    due to:

    - unsuccesful searching for a dominant viral antigen

    - variability of the viruses HIV-1 in the course of time

    - absence of an animal experimental model (even the

    primate‘s infection course isn‘t identical with human)

TREATMENT hypersensitivity type II)

  • Inhibitors of reverse transcriptase - 2 types


  • Inhibitor of viral protease


  • Therapy result to the inhibition of DNA synthesis, stop the progress of the disease and prolong the life of HIV infected persons

Immunoglobulin replacement therapy




Adverse reaction

Ivig is approved for treating
IVIG is approved for treating hypersensitivity type II)

  • X-linked Bruton agammaglobulinemia

  • Common Variable ImmunoDeficiency

  • others

Contra indications
CONTRA-INDICATIONS hypersensitivity type II)

  • Repeated severe side effects

  • Selective IgA deficiency with anaphylactic reaction to immunoglobuline

  • Severe acute infection

Ig administration
IG ADMINISTRATION hypersensitivity type II)

  • Intramuscullar – maximum dose 1,5 g IgG/ week

  • Subcutaneous – total dose/month 400mg/kg, administration every week

  • Intravenous - 400 mg/kg/month

Autoimmune disorders

AUTOIMMUNE DISORDERS hypersensitivity type II)


Clinical categories
CLINICAL CATEGORIES hypersensitivity type II)

  • systemic

    - affect many organs and tissue

  • organ localised

    - affect predominantly one organ accompained by affection of other organs (nonspecific bowel diseases, celiatic disease, AI hepatitis, pulmonary fibrosis)

  • organ specific

    - affect one organ or group of organs connected withdevelopment or function

Examples of systemic autoimmune diseases




Systemic autoimmune diseases

  • Systemic lupus erythematosus

  • Rheumathoid arthritis

  • Sjögren‘s syndrome

  • Dermatopolymyositis

  • Systemic sclerosis

  • Mixed connective tissue disease

  • Antiphospholipid syndrome

  • Vasculitis

  • Sarcoidosis

Systemic lupus erythematosus

  • chronic, inflammatory, multiorgan disorder

  • predominantly affects young women

  • autoantibodies react with nuclear material and attack cell function, immune complexes with dsDNA deposit in the tissue

  • general symptoms: include malaise, fever, weight loss

  • multiple tissueare involved including the skin, mucosa, kidney, joints, brain and cardiovascular system

  • characteristic features: butterfly rash, renal involvement, CNS manifestation, pulmonary fibrosis

Diagnostic tests
DIAGNOSTIC TESTS hypersensitivity type II)

  • a elevated ESR (erythrocyte sedimentation rate), low CRP, trombocytopenia, leukopenia, hemolytic anemia, depresed levels of complement (C4, C3), elevated serum gamma globulin levels

AUTOANTIBODIES hypersensitivity type II)

  • Autoantibodies: ANA, dsDNA (double-stranged), ENA (SS-A/Ro, SS-A/La), Sm, against histones, phospholipids

Rheumatoid arthritis
RHEUMATOID ARTHRITIS hypersensitivity type II)

  • chronic, inflammatory joint disease with systemic involvement

  • predominantly affects women

  • characterized by an inflammatory joint lesion in the synovial membrane, destruction of the cartilage and bone, results in the joint deformation

  • clinical features: arthritis, fever, fatigue, weakness, weight loss

  • systemic features: vasculitis, pericarditis, uveitis, nodules under skin, intersticial pulmonary fibrosis

  • diagnostic tests: elevated C- reactive protein

    and ESR, elevated serum gammaglobulin levels

    - autoantibodies against IgG = rheumatoid factor

    (RF), a-CCP (cyclic citrulline peptid), ANA

    - X-rays of hands and legs- show a periarticular

    porosis, marginal erosion

Antiphospholipid syndrome
Antiphospholipid syndrome hypersensitivity type II)

  • autoimmune disease characterized by vein and arterial thrombosis, repeated abortions

  • accompanied by anti-phospholipid autoantibodies (APA) and antibodies against β2-glykoprotein I

Examples of organ specific autoimmune diseases




Organoleptic autoimmune diseases

  • Ulcerative colitis

  • Crohn‘s disease

  • Coeliac disease

  • Autoimmune hepatitis

  • Primary biliary cirhosis

  • Primary sclerotic cholangoitis

  • Pulmonary fibrosis

Ulcerative colitis
Ulcerative colitis hypersensitivity type II)

  • chronic inflammation of the large intestine mucose and submucose

  • features: diarrhea mixed with blood and mucus

  • extraintestinal features (artritis, uveitis)

  • autoantibodies against pANCA, a- large intestine

Crohn s disease
Crohn‘s disease hypersensitivity type II)

  • the granulomatous inflammation of all intestinal wall with ulceration and scarring that can result in abscess and fistula formation

  • the inflammation of Crohn's disease the most commonly affects the terminal ileum, presents with diarrhea and is accompanied by extraintestinal features - iridocyclitis, uveitis, artritis, spondylitis

  • antibodies againstSaccharomyces cerevisiae (ASCA), a- pancreas

Coeliac disease
Coeliac disease hypersensitivity type II)

  • a malabsorption syndrome characterized by marked atrophy and loss of function of the villi of the jejunum

  • inflammatory bowell disease arise from gliadin exposition

  • autoantibodies against endomysium, the most specific = tissue transglutaminaze; antibodies against gliadin are nonspecific

  • biopsy of the jejunum with findings of the villi atrophy

Organ specific autoimmune diseases

  • Autoimmune endocrinopathy

  • Autoimmune neurological diseases

  • Autoimmune cytopenia

  • Autoimmune cutaneous diseases

  • Autoimmune eye diseases

Autoimmune endocrinopathy

  • Hashimoto‘s thyroiditis

  • Graves-Basedow disease

  • Postpartum thyroiditis

  • Diabetes mellitus I. type

  • Addison‘s disease

  • Autoimmune polyglandular syndrome

  • Pernicious anemia

Hashimoto s thyroiditis
Hashimoto‘s thyroiditis hypersensitivity type II)

  • thyroid disease result to hypothyroidism on the base of lymphocytes and plasma cells infiltrate

  • autoantibodies against thyroidal peroxidase (a-TPO) and/or against thyroglobulin (a-TG)

Grave s disease
Grave‘s disease hypersensitivity type II)

  • thyrotoxicosis from overproduction of thyroid hormone (patient exhibit fatigue, nervousness, increased sweating, palpitations, weight loss,


  • autoantibodies against thyrotropinreceptor,

    autoantibodies cause thyroid cells proliferation

Diabetes mellitus insulin dependent
Diabetes mellitus (insulin- dependent) hypersensitivity type II)

  • characterized by an inability to process sugars in the diet, due to a decrease in or total absence of insulin production

  • results from immunologic destruction of the insuline- producing β-cells of the islets of Langerhans in the pancreas

  • autoantibodies against GAD- glutamic acid decarboxylase = primary antigen), autoantibodies anti- islet cell, anti- insulin

  • islets are infiltrated with B and T cells

Autoimmune neuropathy
AUTOIMMUNE NEUROPATHY hypersensitivity type II)

  • Guillain-Barré syndrome (acute idiopathic polyneuritis)

  • Myasthenia gravis

  • Multiple sclerosis

Myasthenia gravis
Myasthenia gravis hypersensitivity type II)

  • chronic disease resulting from faulty neuromuscular transmission

  • characterized by muscle weakness and fatigue

  • the muscle weakness and neuromuscular dysfunction result from blockage and depletion of acetylcholin receptors at the myoneural junction

  • immunological findings: autoantibodies against Ach receptors

  • ptosis of the eye

Multiple sclerosis
Multiple sclerosis hypersensitivity type II)

  • chronic demyeline disease with abnormal reaction T cells to myeline protein on the base of mimicry between a virus and myeline protein

  • features: weakness, ataxia, impaired vision, urinary bladder dysfunction, paresthesias, mental abberations

  • autoantibodies against MOG (myelin-oligodendrocyte glycoprotein)

  • Magnetic resonance imaging of the brain and spine shows areas of demyelination

  • The cerebrospinal fluid is tested for oligoclonal bands, can provide evidence of chronic inflammation of the central nervous system


IMMUNOSUPRESSION hypersensitivity type II)

non-specific treatment

examples of drugs



Immunosuppressants hypersensitivity type II)

  • are drugs that inhibit or prevent activity of the immune system

  • They are used in immunosuppressive therapy to:

  • Prevent the rejection of transplanted organs and tissues

  • Treat autoimmune diseases

  • Treat some other non-autoimmune inflammatorydiseases (allergic asthma, atopic eczema)

Glucocorticoids hypersensitivity type II)

  • suppress the cell-mediated immunity

  • cytokine production

  • suppress the humoral immunity

  • side-effects: hypertension, dyslipidemia, hyperglycemia, peptic ulcers, osteoporosis, disturbed growth in children

Drugs affecting the proliferation of both T cells and B cells - Cyclophosphamide, Methotrexate, Azathioprine, Mycophenolate mofetil

Drugs blocking the activation of lymphocytes – Tacrolimus, Sirolimus, Cyclosporin A

Monoclonal antibodies - Daclizumab